Slight improvement in response with temozolamide plus radiotherapy vs radiotherapy alone for STS
Radiotherapy alone with concurrent chemoradiotherapy plus temozolamide in locally advanced soft tissue sarcoma at Mayo Hospital Lahore: A randomized controlled trial.JPMA 70: 572. 2020 Apr 1;1:3-1.
Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here
Sixty-four patients with soft tissue sarcomas (STS) were randomized to receive radiation therapy only or radiation therapy plus oral temozolomide. The primary outcome of interest was treatment response as measured by the Response Evaluation Criteria in Solid Tumours (RECIST) criteria. Secondary outcomes of interest included the incidence of adverse events. Results revealed a significantly higher i...
Continuing Medical Education Credits
You could be earning 0.5 CME credits for each report you read.LEARN MORE